DENVER, Colo. (247marketnews.com) — Emerging growth companies continue to focus on commercialization, manufacturing readiness, artificial intelligence integration and differentiated technologies as they pursue long-term growth opportunities.
Manufacturing Validation Advances EL-22 Development
PMGC Holdings’ (NASDAQ:ELAB) subsidiary, NorthStrive Biosciences, announced plans to launch an independent flow cytometry (FACS) analysis program designed to further characterize EL-22, its engineered probiotic therapeutic candidate intended to help preserve muscle during weight-loss treatment, including therapies involving GLP-1 receptor agonists. The planned study will quantitatively measure latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei while comparing those results with previously manufactured material from MOA Life Plus Co. Ltd.
The analytical program represents another development milestone as the company builds the manufacturing and product characterization package necessary for future IND-enabling development. The work is expected to strengthen manufacturing consistency, product identity and analytical validation while supporting regulatory readiness. As interest continues growing around preserving lean muscle mass during GLP-1 weight-loss therapy, NorthStrive is positioning EL-22 as part of a differentiated engineered probiotic platform focused on biologic delivery through genetically engineered bacteria.
Spider Silk Pioneer Gains National Attention as Commercial Scale Advances
Kraig Biocraft Laboratories (OTCQB:KBLB) announced that CEO Kim Thompson has been featured in Authority Magazine’s “Meet the Disruptors” series, highlighting the company’s progress toward commercial-scale recombinant spider silk production. The interview discusses Thompson’s entrepreneurial journey and Kraig Labs’ long-term strategy for bringing one of nature’s strongest fibers into commercial markets.
The company has continued expanding its public profile following recent coverage in National Geographic, where recombinant spider silk production and biomaterials innovation received significant attention. While the latest announcement centers on media recognition rather than operational milestones, it reinforces growing awareness of Kraig Labs’ proprietary genetically engineered silkworm platform as the company continues pursuing commercial production of advanced biomaterials with potential applications across textiles, defense, medical products and industrial materials.
Reverse Stock Split Takes Effect as Company Focuses on Long-Term Listing Compliance
Global Mofy AI (NASDAQ:GMM) announced that its previously approved reverse stock split became effective on June 11, 2026. The Board implemented a 1-for-50 reverse split following shareholder authorization earlier this year, reducing the company’s outstanding share count while maintaining its existing NASDAQ ticker symbol.
The reverse split adjusts the capital structure without changing the company’s underlying business, which remains focused on AI-driven virtual content production, digital asset creation and 3D modeling technologies. Global Mofy continues developing its proprietary Mofy Lab platform and maintains one of China’s largest digital asset libraries supporting film, television, gaming, advertising and AR/VR applications. Reverse stock splits are commonly used by listed companies seeking to maintain exchange listing standards.
Lucyd Smart Glasses Expand AI Capabilities with Claude Integration
Innovative Eyewear (NASDAQ:LUCY) announced that all Lucyd smart glasses will soon support Claude AI alongside existing ChatGPT functionality, allowing users to access multiple large language models through a single application. The update enables voice interaction with Claude while introducing features including AI image generation, document analysis, conversation history, web citations and seamless switching between AI models.
Management also outlined plans for a future hands-free Claude integration expected later in 2026, allowing users to interact with the AI while keeping their phones locked and in their pockets. The announcement reflects the broader trend of expanding artificial intelligence functionality into wearable consumer devices as smart eyewear evolves beyond audio connectivity into AI-assisted productivity and communication tools. Innovative Eyewear continues differentiating its platform through multi-model AI integration while expanding its portfolio under the Lucyd, Nautica, Eddie Bauer and Reebok brands.
Sources
NorthStrive Biosciences / PMGC Holdings Inc. (NASDAQ: ELAB)
Kraig Biocraft Laboratories (OTCQB: KBLB)
Global Mofy AI Limited (NASDAQ: GMM)
Innovative Eyewear (NASDAQ: LUCY)
About 24/7 Market News
In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contactsales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider and the editor of this article holds a personal investment position in XERI, which may be considered a potential conflict of interest. Readers are encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
CONTACT:
24/7 Market News
Editor@247marketnews.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.